Ultrasight , Ltd.

Ultrasight , Ltd. has 2 AI-enabled medical devices on the FDA list. The first decision was on December 17, 2025 and the most recent on December 18, 2025 (PVAD IQ Software). Its most common review panel is Radiology (2 devices).